Cancer Genetics I Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

list the progression of a tumor

A

Normal –> hyperplastic –> dysplastic –> neoplastic –> metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

name 3 proofs of monoclonal tumors

A
  • Examination of X-inactivation in cancer
    • all cells from cancers have the same copy of the X inactivated
  • chromosomal abnormalities of cancers
    • all cells in the tumor contain the same translocation/aberration
  • multiple myelomas produce a monoclonal Ig
    • all myeloma cells in a patient produce the same antibody molecule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe protooncogenes’ role in signal transduction

A
  1. growth factors
  2. growth factor receptors
  3. intracellular tyrosine kinases
  4. G-protein/signal transduction
  5. transcription factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe normal growth factor receptor activation vs mutant

A
  • Proto-oncogenes are normal versions of genes
  • mutant receptors (oncogenes) may undero automatic dimerization, even in the absence of the ligand, which then tells the cell to divide
    • or receptor is truncated and always on
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe Burkitt lymphoma

A
  • Myc oncogene is fused to immunoglobin locus (t 8;14)
    • myc is a transcription factor important for G1/S transition
  • Level of oncogene expression is increased as myc is now under the regulation of IgH promoter because of translocation (active promoter)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe chronic myeloid leukemia

A
  • Bcr-Abl translocation t(9;22) (Philadelphia Chromosome)
  • After translocation, abl (normally a tyrosine kinase) is next to bcr which leads to a hybrid bcr-abl fusion protein
    • bcr-abl fusion protein has unregulated tyrosine kinase activity and keeps telling the cell to divide
    • abl stuck in active form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe Gleevec

A
  • Gleevac (imatinib) is a drug that inhibits the bcr-abl from signalling the cell to divide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe mutations in Ras

A
  • point mutation leads to Ras always bound to GTP (active state)
    • constitutively active
    • tells cell to divide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe oncogenesis by gene amplification

A
  • Double minutes = extrachromosomal fragments of DNA
    • containing an amplified region of the chromosome
    • often seen in tumors where the amplified region includes an oncogene
  • EGFR is often amplified as double minute chromosomes
    • can be visualized with FISH probes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe homogenously staining regions

A
  • abnormal HSRs of chromosomes in cancers often contain amplified oncogenes (can happen in any oncogenes)
    • not production of mutant protein, but overproduction of protein –> uncontrolled cell division
    • N-MYC amplification in neuroblastomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe Wilms tumor

A
  • results from Loss-of-function in the WT1 gene on ch 11
    • encodes a transcription factor that is a tumor suppressor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe tumor suppressor genes

A
  • these are genes that cause cancer when they are lost (Loss of function mutation)
  • tumor suppressor genes = cell cycle control genes, apoptosis promoting genes and/or DNA repair genes
  • one “good” gene is enough for cell cycle control
    • need to lose the function of BOTH to get cancer
    • “two hit” hypothesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe the familial form of cancer

A
  • 10,000 x incidence of sporadic
  • often multiple tumors
  • often occur earlier than sporadic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the two hit hypothesis in sporadic vs familial

A
  • in sporadic, 1st hit is random
  • in familial, 1st hit is inherited
    • therefore, more likely to cause cancer since 2nd hit is all that is needed for cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe the function of Rb protein

A
  • No cyclin/Cdk
    • Rb (hypophosphorylated)/E2F complex still binds DNA
    • blocks transcription
  • Cyclin/Cdk present
    • hyperphosphorylates Rb
    • Rb no longer represses E2Fs
    • E2Fs activate S-phase genes (cell divides)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

name the 4 genes that regulate the phosphorylation of Rb protein

A
  • RB, CDK4, cyclin D gene and CDKN2A (p16(
17
Q

describe the roles of p53

A
  1. slows cell cycle, allows time to do repairs
  2. increase DNA repair capabilities
  3. if damage is too great then it initiates apoptosis and eliminates cell
18
Q

how can p53 activate apoptosis

A
  • increases expression of:
    • pro-apoptotic Bcl-2 family members
    • Fas receptor (CD95)
    • IGFBP-3 (sequesters cell survival proteins)
19
Q

describe Li-Fraumeni syndrome

A
  • caused by inherited mutation of p53
    • 1st hit inherited
    • 2nd hit somatic (responsible for LOH)
  • rare disorder that greatly increases the risk of cancer at a young age
20
Q

describe familial adenomatous polypopsis (FAP)

A
  • caused by mutation in the APC gene on ch 5
    • affects a tumor suppressor gene
    • allelic heterogeneity
  • ~1% of colorectal cancers
  • very high penetrance
21
Q

describe the normal APC pathway

A
  • APC is a component of the WNT signaling pathway
  • APC encodes a tumor suppressor whole role is to down-regulate growth promoting signals
  • WNT signal present
    • destruction complex inactivated
    • B-catenin not degraded
    • B-catenin moves to nucleus, forms complex with TCF-4
    • activates growth promoting genes
  • NO WNT signal
    • APC interacts with B-catenin
    • triggers phosphorylation = ubiquitination and B-catenin degradation
    • therefore, low B-catenin levels
    • No cell growth
22
Q

describe mutation of APC

A
  • mutant APC does not interact with B-catenin in the absence of WNT signal
  • B-catenin NOT phosphorylated and NOT degraded
  • B-catenin interacts with TCF-4 and activates growth (in the absence of WNT signal)
23
Q

describe Hereditary Non-polyposis Colon Cancer

A
  • few polyps but progress rapidly
    • as opposed to many polyps that progress slowly in FAP
  • defects in mismatch DNA repair genes (MMR genes)
  • cells accumulate mutations at rate up to 1000x higher than normal
  • tumors also exhibit microsatellite instability (short repetitive sequences of DNA)
24
Q

contrast FAP and HNPCC

A
  • FAP
    • APC mutation
    • numerous polyps
  • HNPCC
    • MSH2/MLH1 (mismatch repair proteins)
    • fewer polyps
    • microsatellite instability
25
Q

describe BRCA1/BRCA2

A
  • code for breast cancer type 1/2 suspectibility protein
    • involved in DNA repair or apoptosis when DNA can’t be repaired
    • allelic heterogeneity
26
Q

describe HER-2 overexpression and treatment

A
  • HER-2 overexpression is found in sporadic breast cancer
  • Herceptin drug (antibody) binds to HER2 and prevents binding of EGF to HER2
    • addition of Herceptin to the treatment results in decreased tumor cell proliferation
27
Q

describe epigenetics in tumorigenesis

A
  • DNA methylation and histone modifications are frequently altered in tumor cells
  • tumor suppresor loci are frequently hypermethylated in cancer cells (silencing of tumor suppressor genes)
28
Q

describe the role of miRNAs in tumorigenesis

A
  • miRNAs act to reduce the expression of genes by targeting specific mRNAs
  • tumorigenesis caused by 2 methods:
    • reduction of miRNA that could have inhibited oncogene RNA
    • increase in miRNA that inhibits tumor suppressor RNA